Howard Maibach, MD

Pitfalls in clinical trials reveal need for well tolerated, more effective depigmenting agents.

Saxena S, Andersen RM, Maibach HI PMID: 25669434

North American contact dermatitis group patch test results: 2011-2012.

Warshaw EM, Maibach HI, Taylor JS, Sasseville D, DeKoven JG, Zirwas MJ, Fransway AF, Mathias CG, Zug KA, DeLeo VA, Fowler JF, Marks JG, Pratt MD, Storrs FJ, Belsito DV PMID: 25581671

Measurement, analysis and prediction of topical UV filter bioavailability.

Roussel L, Gilbert E, Salmon D, Serre C, Gabard B, Haftek M, Maibach HI, Pirot F PMID: 25526673

Emerging topical onychomycosis therapies - quo vadis?

Elkeeb R, Hui X, Murthy N, Maibach HI PMID: 25401504

Cathepsin D repairing role in photodamaged skin barrier.

Zheng Y, Chen H, Lai W, Xu Q, Liu C, Wu L, Maibach HI PMID: 25402676

Shaving effects on percutaneous penetration: clinical implications.

Hamza M, Tohid H, Maibach H PMID: 25363065

Patch testing in children from 2005 to 2012: results from the North American contact dermatitis group.

Zug KA, Pham AK, Belsito DV, DeKoven JG, DeLeo VA, Fowler JF, Fransway AF, Maibach HI, Marks JG, Mathias CG, Pratt MD, Sasseville D, Storrs FJ, Taylor JS, Warshaw EM, Zirwas MJ PMID: 25384228

Animal models for percutaneous absorption.

Jung EC, Maibach HI PMID: 25345378

Using skin for drug delivery and diagnosis in the critically ill.

Liu X, Kruger P, Maibach H, Colditz PB, Roberts MS PMID: 25305335

Perspectives on percutaneous penetration: Silica nanoparticles.

Nafisi S, Schäfer-Korting M, Maibach HI PMID: 25286334